{"schema_version":"secwatch.filing_event.v1","accession":"0000105770-25-000090","form_type":"8-K","ticker":"WST","cik":"0000105770","company_name":"WEST PHARMACEUTICAL SERVICES INC","filed_at":"2025-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.682179+00:00","generated_at":"2026-05-17T02:25:34.284283+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"West Pharma Q3 net sales $804.6M (+7.7%), adjusted EPS $1.96; raises FY guidance","bullets":["Proprietary Products HVP Components net sales $390M, +16.3% YoY, driven by GLP-1 products and HVP conversion.","Full-year 2025 net sales guidance raised to $3.060-3.070B; adjusted EPS guidance raised to $7.06-7.11.","Q4 2025 guidance: net sales $790-800M, adjusted diluted EPS $1.81-1.86.","Free cash flow nine months $293.9M, +53.7% YoY; repurchased 552,593 shares for $134.0M."],"urls":{"canonical":"https://secwatch.observer/filing/0000105770-25-000090","json":"https://secwatch.observer/filing/0000105770-25-000090.json","markdown":"https://secwatch.observer/filing/0000105770-25-000090.md","text":"https://secwatch.observer/filing/0000105770-25-000090.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105770/000010577025000090/0000105770-25-000090-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105770/000010577025000090/wst-20251023.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:25:34.284283+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}